NBIX
Neurocrine Biosciences, Inc.When NBIX passed all Ten ChecksNeurocrine Biosciences, Inc.
history · not a forecastOver the past 10 years, NBIX has passed all Ten Checks on 15 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +13.2% in Jul 2018, still rising at session 20.
- Jun 2025+5.4% -2.2%
- May 2024+1.8% -4.3%
- Oct 2023+2.7% -6.6%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about NBIX’s checks
How many technical checks does NBIX pass right now?
As of the Aug 13, 2026 close, NBIX passes 5 of 10 fixed technical checks — the checks not passing: holding above short-term average, outperforming the market, stop distance within range, adequate stop room, quiet pullback volume.
Why does NBIX fail the "stop distance within range" check?
A stop at $150.19 is only 0.4% below NBIX's price — tighter than the 2% floor, so the risk check fails (too little room to work). It passes once the stop sits 2–8% below price.
What price would change NBIX's check count?
The nearest flip level is "stop distance within range" passes on a close between $153.26 – $163.25. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.